KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Johnson & Johnson (JNJ) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Johnson & Johnson (JNJ) over the last 17 years, with Q3 2025 value amounting to 29.31%.

  • Johnson & Johnson's EBIT Margin rose 69000.0% to 29.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 25.46%, marking a year-over-year increase of 7500.0%. This contributed to the annual value of 23.66% for FY2024, which is 16100.0% down from last year.
  • According to the latest figures from Q3 2025, Johnson & Johnson's EBIT Margin is 29.31%, which was up 69000.0% from 27.99% recorded in Q2 2025.
  • In the past 5 years, Johnson & Johnson's EBIT Margin ranged from a high of 34.44% in Q1 2023 and a low of 15.98% during Q4 2024
  • In the last 5 years, Johnson & Johnson's EBIT Margin had a median value of 27.01% in 2023 and averaged 25.6%.
  • Data for Johnson & Johnson's EBIT Margin shows a peak YoY increase of 78200bps (in 2023) and a maximum YoY decrease of -145700bps (in 2023) over the last 5 years.
  • Johnson & Johnson's EBIT Margin (Quarter) stood at 28.31% in 2021, then decreased by -6bps to 26.5% in 2022, then decreased by -25bps to 19.87% in 2023, then decreased by -20bps to 15.98% in 2024, then surged by 83bps to 29.31% in 2025.
  • Its last three reported values are 29.31% in Q3 2025, 27.99% for Q2 2025, and 28.24% during Q1 2025.